ASP Isotopes (ASPI): Failed Tech + Paid Stock Promotion + “Microcap Fraudsters” (Honig & Stetson) = Nuclear Meltdown – Fuzzy Panda Research
ASP Isotopes (ASPI) exposed: Obsolete uranium enrichment tech, SEC-banned promoters, fraudulent stock scheme with zero NRC licensing and misleading investor claims revealed by Fuzzy Panda Research investigation
ASP Isotopes (ASPI) is promoting obsolete laser uranium enrichment technology previously abandoned by governments worldwide after billions in failed investment, while concealing ties to notorious penny stock promoters banned by the SEC, according to extensive research by Fuzzy Panda Research.
Stock info:
- Ticker: ASPI (NASDAQ)
- Position: Fuzzy Panda Research and its affiliates hold a short position in ASPI shares
Why it matters:
- ASPI is recycling a 20-year-old laser enrichment technology (AVLIS) that was abandoned by the US ($2 billion spent over 26 years), Japan, France, Iran, and Iraq after proving commercially unviable
- Industry executives from Centrus, TerraPower, and Cameco dismiss ASPI's technology as "uneconomic," "impossible to scale," and worth "not even $2 million"
- The company has deep, undisclosed ties to Barry Honig (lifetime penny stock ban) and John Stetson (10-year ban), notorious SEC-charged stock promoters whose previous ventures lost investors 97-99% on average
- ASPI grossly misrepresents facility costs at "under $10 million" while industry experts project hundreds of millions to billions, with one Centrus executive stating "at least a billion dollars" for a commercial plant
- The company lacks even basic NRC licensing, has zero patents (claiming "trade secrets" for widely-documented technology), and uses images recycled from 15-year-old NRC documents
- ASPI operates from a Regus co-working space after starting in a $73/month virtual office, while its South African subsidiaries share an address with a bankrupt company with no evidence of actual operations
Zoom in:
- ASPI's non-binding agreement with TerraPower involves zero capital commitment and is viewed by industry executives as merely promotional window dressing
- CEO Paul Mann previously served as CFO at PolarityTE, another controversial stock promotion with significant financial troubles
- The company employs multiple paid stock promotion services (RedChip, Ocean Wall, Emerging Growth Conference) with fees of $12,500 monthly plus additional promotional bursts
- ASPI failed to compete for the Department of Energy's HALEU supply contract, a telling sign of its technology's lack of viability
- An anonymous Los Alamos applied physicist expressed serious doubts about ASPI's laser enrichment claims, particularly regarding uranium ionization efficiency
- The company's funding structure traces back to shell companies linked to the Honig network within 90 days of incorporation
FAQs:
What is AVLIS technology and why does it matter for ASPI?
AVLIS (Atomic Vapor Laser Isotope Separation) is a uranium enrichment method using lasers that was extensively researched and ultimately abandoned by multiple governments due to extreme costs and technical limitations. Despite billions invested globally, the technology proved commercially unviable. ASPI's reliance on this outdated method undermines its claims of having revolutionary enrichment technology.
Who are Barry Honig and John Stetson, and how are they connected to ASPI?
Barry Honig and John Stetson are stock promoters who faced SEC charges for fraudulent "pump-and-dump" schemes. Honig received a lifetime ban from penny stocks, while Stetson received a 10-year ban. According to Fuzzy Panda's research, they maintain concealed stakes in ASPI through shell companies and family trusts, including Titan Multi-Strategy Fund and the Tarra Stetson Revocable Trust.
How realistic are ASPI's cost projections for uranium enrichment facilities?
ASPI claims it can build commercial enrichment facilities for under $10 million each. However, industry experts from companies like TerraPower, Centrus, and Cameco consistently estimate actual costs at hundreds of millions to billions of dollars. One former TerraPower executive stated a pilot facility alone would cost "hundreds of millions," while a Centrus executive estimated "at least a billion dollars" for commercial scale.
What regulatory hurdles does ASPI face?
ASPI currently lacks even basic Nuclear Regulatory Commission (NRC) licensing required for uranium enrichment. Industry experts note that obtaining such licensing typically takes 10-15 years, contradicting ASPI's aggressive timeline claims. Additionally, the technology's previous rejection by multiple governments after extensive testing presents a significant regulatory precedent against its approval.
Why would TerraPower sign a memorandum of understanding with ASPI if the technology isn't viable?
According to former executives interviewed in the report, non-binding MOUs require zero capital commitment and serve primarily as publicity tools rather than genuine strategic partnerships. Industry experts suggest these agreements offer "optionality" with minimal risk, allowing larger companies to maintain awareness of potential technologies without significant investment.
How does ASPI's stock promotion strategy compare to legitimate companies?
ASPI engages multiple paid stock promotion services (RedChip, Ocean Wall, Emerging Growth Conference) with documented fees of $12,500 monthly plus additional promotional payments. This heavy reliance on paid promotion mirrors patterns seen in previous Honig & Stetson affiliated companies that experienced dramatic price collapses. Legitimate companies typically rely on actual technological achievements and business fundamentals rather than extensive paid promotion.
Disclaimer
This summary is based on a report by Fuzzy Panda Research. For the full, detailed analysis, please refer to the original source material: https://fuzzypandaresearch.com/aspi-honig-stetson-paid-stock-promotion/
ShortReport.fyi is not the author or originator of the content provided in this publication. We act solely as a distributor of the content and do not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of the information presented. Each author retains full ownership and responsibility for their respective content, including any opinions, projections, or analyses expressed therein.
This publication is for informational purposes only and should not be construed as legal, business, investment, or tax advice. Readers are advised to consult the original source material and seek guidance from qualified professionals before making any decisions based on the information contained herein.
ShortReport.fyi disclaims all liability for any loss or damage arising from reliance on the content provided by third parties. The views expressed in these materials are solely those of the respective authors and do not necessarily reflect the views or opinions of ShortReport.fyi.